TY  - GEN
AU  - Hurtado-Guerrero, Isaac
AU  - Pinto-Medel, María Jesús
AU  - Urbaneja, Patricia
AU  - Rodriguez-Bada, Jose Luis
AU  - León, Antonio
AU  - Guerrero, Miguel
AU  - Fernández, Óscar
AU  - Leyva, Laura
AU  - Oliver-Martos, Begoña
PY  - 2017
DO  - 10.1371/journal.pone.0170031
UR  - http://hdl.handle.net/20.500.12105/17283
AB  - Interferon beta (IFNß) is a common treatment used for multiple sclerosis (MS) which acts through the activation of the JAK-STAT pathway. However, this therapy is not always effective and currently there are no reliable biomarkers to predict...
LA  - eng
PB  - Public Library of Science (PLOS)
KW  - Biomarcadores
KW  - Citometría de flujo
KW  - Humanos
KW  - Leucocitos mononucleares
KW  - Monocitos
KW  - Esclerosis múltiple
KW  - Fenotipo
KW  - Factor de Transcripción STAT1
KW  - Factor de Transcripción STAT2
KW  - Resultado del tratamiento
KW  - Biomarkers
KW  - Flow Cytometry
KW  - Humans
KW  - Interferon beta-1a
KW  - Interferon-beta
KW  - Leukocytes, Mononuclear
KW  - Monocytes
KW  - Multiple Sclerosis
KW  - Phenotype
KW  - STAT1 Transcription Factor
KW  - STAT2 Transcription Factor
KW  - Treatment Outcome
TI  - Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß
TY  - research article
ER  -